Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Ordinary shares, nominal value 0.002 GBP per share
-
Shares outstanding
-
145,993,531
-
Total 13F shares
-
74,395,267
-
Share change
-
+3,114,648
-
Total reported value
-
$840,663,455
-
Put/Call ratio
-
28%
-
Price per share
-
$11.30
-
Number of holders
-
69
-
Value change
-
+$66,659,727
-
Number of buys
-
45
-
Number of sells
-
13
Institutional Holders of Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share (CNTA) as of Q1 2024
As of 31 Mar 2024,
Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share (CNTA) was held by
69 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
74,395,267 shares.
The largest 10 holders included
Medicxi Ventures Management (Jersey) Ltd, GENERAL ATLANTIC, L.P., EcoR1 Capital, LLC, Vida Ventures Advisors, LLC, PERCEPTIVE ADVISORS LLC, First Light Asset Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Point72 Asset Management, L.P., and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
69
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.